このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Cardlytics マネジメント

マネジメント基準チェック /24

Cardlytics'の CEO はKarim Temsamaniで、 Sep2022年に任命され、の在任期間は 1.75年です。の年間総報酬は$ 1.89Mで、 26.5%給与と73.5%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.79%を直接所有しており、その価値は$ 3.18M 。経営陣と取締役会の平均在任期間はそれぞれ1.8年と0.8年です。

主要情報

Karim Temsamani

最高経営責任者

US$1.9m

報酬総額

CEO給与比率	26.5%
CEO在任期間	1.8yrs
CEOの所有権	0.8%
経営陣の平均在職期間	1.8yrs
取締役会の平均在任期間	less than a year

経営陣の近況

Recent updates

Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain

Jul 02

Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

May 31

Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Apr 17

Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Mar 03

Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Jan 10

Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

Oct 12

Cardlytics: 6 Bear Cases To Consider

Oct 10

Cardlytics: Trying To Stem The Bleeding

Sep 27

BitPay adds Cardlytics-powered rewards program to its crypto prepaid card

Aug 10

Cardlytics slumps 16% after missing top and bottom line estimates

Aug 02

CEO報酬分析

Cardlytics の収益と比較して、Karim Temsamani の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	-US$173m
Dec 31 2023	US$2m	US$500k	-US$135m
Sep 30 2023	n/a	n/a	-US$412m
Jun 30 2023	n/a	n/a	-US$382m
Mar 31 2023	n/a	n/a	-US$485m
Dec 31 2022	US$17m	US$167k	-US$465m

報酬と市場: Karimの総報酬 ($USD 1.89M ) は、 US市場 ($USD 2.44M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Karimの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Karim Temsamani (50 yo)

1.8yrs

在職期間

US$1,885,944

報酬

Mr. Karim Temsamani serves as Chief Executive Officer and Director of Cardlytics, Inc. since September 01, 2022. He joined Stripe in April 2019 to lead strategic vision and execution across product and eng...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Karim Temsamani	CEO & Director	1.8yrs	US$1.89m	0.79% $ 3.1m
Alexis DeSieno	Chief Financial Officer	less than a year	US$5.35m	データなし
Amit Gupta	COO & GM of Bridg	1.5yrs	US$2.66m	0.25% $ 991.2k
Nick Lynton	Chief Legal & Privacy Officer and Secretary	2yrs	US$1.06m	0.15% $ 579.8k
Peter Chan	Chief Technology Officer	3.1yrs	データなし	データなし
Peter Davies	Head of Sales Strategy & Operations	4yrs	データなし	データなし
Carson Napps	Head of People	1.1yrs	データなし	データなし
Jose Singer	Chief Product Officer	2.2yrs	データなし	データなし
Evelyne Forester	Chief Business Officer	less than a year	データなし	データなし

1.8yrs

平均在職期間

45.5yo

平均年齢

経験豊富な経営陣: CDLXの経営陣は経験豊富とはみなされません ( 1.8年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Karim Temsamani	CEO & Director	1.8yrs	US$1.89m	0.79% $ 3.1m
Scott Hill	Independent Director	less than a year	US$132.77k	データなし
Liane Hornsey	Independent Director	less than a year	データなし	データなし
John Klinck	Independent Chairperson of the Board	7.8yrs	US$216.85k	0.11% $ 433.0k
Andre Fernandez	Independent Director	less than a year	データなし	データなし
Jessica Jensen	Independent Director	4yrs	US$205.00k	0.079% $ 311.9k
Aimée Lapic	Independent Director	5.3yrs	US$210.00k	0.088% $ 346.7k
Jonathan Francis	Independent Director	less than a year	データなし	データなし
Alex Mishurov	Independent Director	less than a year	データなし	0.26% $ 1.0m

0.8yrs

平均在職期間

54yo

平均年齢

経験豊富なボード: CDLXの取締役会は経験豊富ではない ( 0.8年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Cardlytics マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Cardlytics, Inc., Annual General Meeting, May 23, 2024

Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors

Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors

CEO & Director notifies of intention to sell stock

CEO & Director notifies of intention to sell stock

High number of new directors

Recent updates

Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain

Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

Consensus EPS estimates fall by 33%

Price target decreased by 21% to US$14.00

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Cardlytics, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Cardlytics, Inc. to Report Q1, 2024 Results on May 08, 2024

The Power Of Cardlytics' Data Partnerships Including Bank of America

Cardlytics, Inc., Annual General Meeting, May 23, 2024

Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors

Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors

Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors

CEO & Director notifies of intention to sell stock

Now 35% undervalued

Consensus estimates of losses per share improve by 18%

Cardlytics, Inc. has completed a Follow-on Equity Offering in the amount of $50 million.

Cardlytics, Inc. has filed a Follow-on Equity Offering in the amount of $50 million.

Price target increased by 46% to US$17.00

New major risk - Share price stability

No longer forecast to breakeven

Cardlytics, Inc. Provides Earnings Guidance for the First Quarter of 2024

CEO & Director notifies of intention to sell stock

Cardlytics, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Cardlytics: Good Prospects But Macro Uncertain

High number of new directors

COO & GM of Bridg exercised options and sold US$443k worth of stock

Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk

CEO & Director notifies of intention to sell stock

Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?

Kigo, LLC acquired HSP EPI Acquisition, LLC from Cardlytics, Inc. (NasdaqGM:CDLX).

CEO & Director exercised options and sold US$332k worth of stock

Consensus EPS estimates upgraded to US$1.32 loss, revenue downgraded

Cardlytics, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Cardlytics, Inc. Announces Resignation of Tony Weisman as Member of the Board and as Member of the Nominating and Corporate Governance Committee

Cardlytics, Inc. to Report Q3, 2023 Results on Nov 08, 2023

We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt

Cardlytics, Inc. Appoints Alex Mishurov as Independent Director

CEO & Director recently sold US$2.9m worth of stock

Cardlytics, Inc. Announces Board Member Changes

Insider recently sold US$172k worth of stock

Consensus EPS estimates fall by 29%, revenue upgraded

Cardlytics, Inc. Provides Earnings Guidance for the Third Quarter 2023

New minor risk - Shareholder dilution

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

No longer forecast to breakeven

Insufficient new directors

Cardlytics, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Cardlytics Appoints Alexis Desieno as New Chief Financial Officer

Cardlytics, Inc. Announces Board Changes

Cardlytics, Inc. Announces Board Changes

CEO & Director notifies of intention to sell stock

Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?

Consensus EPS estimates upgraded to US$1.87 loss, revenue downgraded

Price target increased by 9.8% to US$6.70

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Cardlytics, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Price target increased by 8.9% to US$6.10

Full year 2022 earnings: EPS misses analyst expectations

Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Price target decreased by 18% to US$7.40

Cardlytics, Inc. to Report Q4, 2022 Results on Mar 01, 2023

Cardlytics Appoints Amit Gupta as Chief Operating Officer

Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Cardlytics, Inc. Announces Board Changes

Price target decreased to US$9.80

Co-Founder & Executive Chairman notifies of intention to sell stock

Consensus forecasts updated

マネジメント基準チェック /24